Welcome to Biotech Banter, where we bring you exclusive insights from top experts in the biotech industry. Our thought leaders and seasoned professionals explore the challenges and opportunities of advancing cell and gene therapies to clinic.
A robust pharmaceutical quality system forms the foundation of safe and efficient drug manufacturing. It ensures that products meet stringent quality standards, safeguarding patients, adhering to regulatory mandates, and bolstering a company’s standing in the industry. The adoption and adherence to such a system signify a company’s dedication to excellence.
In our second episode, we’re joined by Jackie Panter, Chief Quality and Compliance Officer at BioCentriq, and Dr. Chat de Silva, Executive Director of Business Development. Jackie shares her expertise on the intricacies of pharmaceutical quality systems, explaining their importance, the optimal methods for implementation, taking into account factors like company size, complexity, product portfolio, and regulatory demands, and much more.
Tune in and gather knowledge to design a system that will propel your organization to the forefront of the industry.
Click here to listen to the first episode now!
Subscribe and Connect!
With expert insights, tips, and information, Biotech Banter will help you discover what it takes to set the stage for successful clinical manufacturing, how to decide if working with a CDMO is the right move for your project, how to get the most out of your partnership with a CDMO, and more.
Don’t miss out on the opportunity to stay at the forefront of cell therapy advancements and to obtain expert opinions, tips, and lessons. Subscribe to Biotech Banter now to get alerted when the next episode is released! We’d also love to hear your thoughts, questions, or suggestions for additional episodes. Email us at imane.benbelkheir@biocentriq.com if you have anything to share with us.